Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P

PLoS ONE

Volumn 2, Issue 10, 2007, Pages

  Semple, Malcolm G ^a   Dankert, Hinke M ^a   Ebrahimi, Bahram ^a   Correia, Jailson B ^a   Booth, J Angela ^a   Stewart, James P ^a   Smyth, Rosalind L ^a   Hart, C Anthony ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 9; OXYGEN; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; SUBSTANCE P; UREA;

ARTICLE; ARTIFICIAL VENTILATION; BODY WEIGHT; CELL FREE SYSTEM; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; EFFECT SIZE; FEMALE; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; INFANT; INFORMATION PROCESSING; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL ASPIRATION; OXYGEN THERAPY; PREDICTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFLAMMATION; SUPERNATANT; VIRAL BRONCHIOLITIS; VIRUS LOAD; VIRUS PATHOGENESIS; BRONCHIOLITIS; INNATE IMMUNITY; METABOLISM; NEWBORN; RESPIRATORY SYSTEM; VIROLOGY; VIRUS INFECTION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; RESPIRATORY SYNCYTIAL VIRUS;

BRONCHIOLITIS; FEMALE; HUMANS; IMMUNITY, NATURAL; INFANT; INFANT, NEWBORN; INTERFERON TYPE II; INTERLEUKIN-9; MALE; OXYGEN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY SYSTEM; SUBSTANCE P; UREA;

EID: 42049100174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001038     Document Type: Article

References (48)

1. Excler JL, Girard M (2005) State of the art of new vaccines. Research & Development. WHO Initiative for Vaccine Research. 14-16. http://www.who.int/entity/vaccine_research/documents/Dip%20814.pdf.
2. Leader S, Kohlhase K (2002) Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J 21: 629-632.
3. Wright PF, Cutts FT (2000) Generic protocol to examine the incidence of lower respiratory infection due to respiratory syncytial virus in children less than five years of age. WHO/V&B/00.08: http://www.who.int/vaccine_research/documents/en/syncytial-virus.pdf.
4. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, et al. (1999) Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354: 541 545.
5. Bont L, Aalderen WM, Kimpen JL (2000) Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis. Paediatr Respir Rev 1: 221-227.
6. McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL (2003) Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child 88: 922-926.
7. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS (2007) The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 20: 108-119.
8. King KA, Hu C, Rodriguez MM, Romaguers. R, Jiang X, et al. (2001) Exaggerated neurogenic inflammation and substance Preceptor upregulation in RSV-infected weanling rats. Am J Respir Cell Mol Biol 24: 101-107.
9. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, et al. (2001) Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis 164: 355-358.
10. McNamara PS, Flanagan BF, Baldwin LM, Newland P, Hart CA, et al. (2004) Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet 363: 1031-1037.
11. DeVincenzo JP, El Saleeby CM, Bush AJ (2005) Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis 191: 1861-1868.
12. McNamara PS, Flanagan BF, Selby AM, Hart CA, Smyth RL (2004) Pro and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J 23: 106-112.
13. de Blic J, Midulla F, Barbato A, Clement A, Dab I, et al. (2000) Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society.-Eur Respir J 15: 217-231.
14. Ratjen F, Bruch J (1996) Adjustment of bronchoalveolar lavage volume to body weight in children. Pediatr Pulmonol 21: 184-188.
15. Heaney LG, Stevenson EC, Turner G, Cadden IS, Taylor R, et al. (1996) Investigating paediatric airways by non-bronchoscopic lavage: normal cellular data. Clin Exp Allergy 26: 799-806.
16. Pierson RN Jr, Wang J, Thornton JC (2000) Body composition comes of age: a modest proposal for the next generation. The new reference man. Ann N Y Acad Sci 904: 1-11.
17. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, et al. (1986) Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 60: 532-538.
18. Mills PC, Litster AL (2005) Using urea dilution to standardisc components of pleural and bronchoalveolar lavage fluids in the dog. N Z Vet J 53: 423-428.
19. Mills PC, Litster A (2006). Using urea dilution to standardise cellular and non-cellular components of pleural and bronchoalveolar lavage (BAL) fluids in the cat. J Feline Med Surg 8: 105-110.
20. Talke H, SCHUBERT GE (1965) ENZYMATIC UREA DETERMINATION IN THE BLOOD AND SERUM IN THE WARBURG OPTICAL TEST. J. Klin Wochensch 43; 174-175.
21. Greensill J, McNamara PS, Dove W, Flanagan B, Smyth RL, et al. (2003) Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis 9: 372-375.
22. Hosmer DW Jr, Wang CY, Lin IC, Lemeshow S. (1978) A computer program for stepwise logistic regression using maximum likelihood estimation. Comput Programs Biomed 8: 121-134.
23. Smyth RL, Mobbs KJ, O'Hea U, Ashby D, Hart CA (2002) Respiratory syncytial virus bronchiolitis: Disease severity, interleukin-8, and virus genotype. Pediatr Pulmonol 33: 339-346.
24. Hosmer DW Jr, Lemeshow S (1980) Goodness of fit tests for the multiple logistical regression model. Commun Stat A9: 1043-1069.
25. Lockitch G, Halstead AC, Albersheim S, MacCallum C, Quigley G (1988) Age-and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer. Clin Chem 34: 1622-1625.
26. Schwartz D, Lellouch J (1967) Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 20: 637-648.
27. Young HA, Hardy KJ (1995) Role of interferon-gamma in immune cell regulation. J Leukocyte Biol 58: 373-381.
28. Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15: 749-795.
29. Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, et al. (2006) Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 12: 1023-1026.
30. Lo MS, Brazas RM, Holtzman MJ (2005) Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 79: 9315-9319.
31. Jartti T, Lehtinen P, Vuorinen T, Osterback R, van den HB, et al. (2004) Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis 10: 1095-1101.
32. Hall CB, Douglas RGJ, Geiman JM (1975) Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis 132: 151-156.
33. Wright PF, Gruber WC, Peters M, Reed G, Zhu Y, et al. (2002) Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. J Infect Dis 185: 1011-1018.
34. Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO (2003) Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 168: 633-639.
35. Perkins SM, Webb DL, Torrance SA, El SC, Harrison LM, et al. (2005) Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus. J Clin Microbiol 43: 2356-2362.
36. Everard ML, Swarbrick A, Wrightham M, McIntyre J, Dunkley C, et al. (1994) Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 71: 428-432.
37. Piedimonte G, Rodriguez MM, King KA, McLean S, Jiang X (1999) Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs. Am J Physiol 277: L831-L840.
38. Kaltreider HB, Ichikawa S, Byrd PK, Ingram DA, Kishiyama JL, et al. (1997) Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am J Respir Cell Mol Biol 16: 133-144.
39. Braunstein G, Fajac I, Lacronique J, Frossard N (1991) Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis. Am Rev Respir Dis 144: 630-635.
40. Tortorolo L, Langer A, Polidori G, Vento G, Stampachiacchere B, et al. (2005) Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection. Am J Respir Crit Care Med 172: 233-237.
41. Sabogal C, Auais A, Napchan G, Mager E, Zhou BG, et al. (2005) Effect of respiratory syncytial virus on apnea in weanling rats. Pediatr Res 57: 819-825.
42. Tripp RA, Dakhama A, Jones LP, Barskey A, Gelfand EW, et al. (2003) The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P. J Virol 77: 6580-6584.
43. Temann UA, Geba GP, Rankin JA, Flavell RA (1998) Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 188. 1307-1320.
44. Reader JR, Hyde DM, Schelegle ES, Aldrich MC, Stoddard AM, et al. (2003) Interleukin-9 induces mucous cell metaplasia independent of inflammation. Am J Respir Cell Mol Biol 28: 664-672.
45. Dong O, Louahed J, Vink A, Sullivan CD, Messler CJ, et al. (1999) IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur J Immunol 29: 2130-2139.
46. Nicolaides NC, Holroyd KJ, Ewart SL, Eleff SM, Kiser MB, et al. (1997) Interleukin 9: a candidate gene for asthma. Proc Natl Acad Sci U S A 94: 13175-13180.
47. Hjalmarson O, Sandberg K (2002) Abnormal lung function in healthy preterm infants. Am J Respir Crit Care Med 165: 83-87.
48. Friedrich L, Stein RT, Pitrez PM, Corso AL, Jones MH (2006) Reduced lung function in healthy preterm infants in the first months of life. Am J Respir Crit Care Med 173: 442-447.